Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.
about
My treatment approach to rheumatoid arthritisPhotodynamic therapy induces an immune response against a bacterial pathogenPotential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical reviewDevelopment of macromolecular prodrug for rheumatoid arthritisEmpowering employees with chronic diseases; development of an intervention aimed at job retention and design of a randomised controlled trial.Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohortTrends in biologic therapies for rheumatoid arthritis: results from a survey of payers and providers.Biologic rheumatoid arthritis therapies: do we need more comparative effectiveness data?Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota.Tension at the borders: perceptions of role overload, conflict, strain and facilitation in work, family and health roles among employed individuals with arthritis.A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivityFacilitating empowerment in employees with chronic disease: qualitative analysis of the process of change.Inflammatory arthritis: an overview for primary care physicians.Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy.Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis.Can bone loss in rheumatoid arthritis be prevented?Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database.Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.Social security work disability and its predictors in patients with fibromyalgia.Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort.Randomized prospective study of a work place ergonomic intervention for individuals with rheumatoid arthritis and osteoarthritis.Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study.Work ability: a new outcome measure in rheumatoid arthritis?Work productivity loss in early arthritis during the first 3 years of disease: a study from a French National Multicenter Cohort.Treatment with Adenosine Receptor Agonist Ameliorates Pain Induced by Acute and Chronic Inflammation.Burden of Depression among Working-Age Adults with Rheumatoid Arthritis.Pharmacologic Effect of Miao Medicine Maxim. on Collagen-Induced Arthritis in Rats
P2860
Q26829955-F8E86419-7596-4F7E-9FE6-4E4A66396C44Q27013274-D635E3EF-F19F-4160-AE81-C57697FC6D67Q27024465-CED338CA-E90E-49A7-A991-8F392C7A1528Q27693332-105E1050-92D5-4581-A5CA-907DCD8480D3Q33382516-849210F7-81F5-4971-9A9B-A277DF103E2DQ33413158-C0FEF885-DD1D-4821-9B4A-A70D2E1135FDQ33714787-C8740EBE-E407-421F-9326-3422FC704E22Q34183220-B31A34CF-E29E-49E4-A623-93B76C530B0CQ35101759-8767D890-6390-4D4C-9F50-499522D846EDQ35683446-DE8D64AE-9E25-405B-9F11-CB3290EDAB86Q36266374-26A8D0F9-C08B-404C-93C1-7912AFABDB55Q36885296-E95258E0-4786-4AB9-A646-37E7F35FE27EQ36923257-CC94C32F-2FA1-4C3F-97A3-CDE9B06EE8F4Q37416160-52D63557-3578-4E00-A17E-FA1ED3AF26D4Q37427257-3B01DCFD-4078-45B5-AD81-35081BCA7EABQ38055244-95B06E5B-878C-4448-9126-6635CDBFD9CFQ38099408-285ED8A3-00D2-48B5-A4F3-07318EE45A5BQ38115190-AD5E1245-B9AB-4290-AEC8-5F72226948CAQ38813411-7E8A306D-1E64-40BC-BCE8-D3A3818E03B7Q38829365-66A16915-4D55-4E46-A551-F22D8757F124Q39888893-9D187B76-6338-42CE-98BF-E952649E6781Q43943761-6DAD76FC-4C9D-49A0-9793-25CE40C2617AQ45769410-7BC39A2A-7C85-42FE-A438-EC31F314D725Q46017740-6CE46428-7F81-4B62-A124-362A4B9CEA9EQ48445350-3A34D729-849C-4BFF-87BA-FF62C9CFF8E3Q48913303-E77723AD-F868-40CE-BAD1-1F4FCB6D0784Q50661536-D7B0E33F-332C-409E-90E0-76C9D7E495B2Q53096946-555AF715-13F9-4A4A-8B59-C611606D75ECQ55462217-005069D4-F22B-4DF3-8460-43E5262A8346Q58572457-6ED18081-24F2-4F99-95EE-120B19742D0E
P2860
Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@ast
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@en
type
label
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@ast
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@en
prefLabel
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@ast
Contemporary prevalence and in ...... heumatoid arthritis in the US.
@en
P2860
P356
P1476
Contemporary prevalence and in ...... rheumatoid arthritis in the US
@en
P2093
Frederick Wolfe
Saralynn Allaire
P2860
P304
P356
10.1002/ART.23538
P577
2008-04-01T00:00:00Z